Zhejiang Jianfeng Group Co., Ltd. (SHA:600668)

Market Cap	3.12B -36.2%
Revenue (ttm)	2.43B -13.6%
Net Income	-214.71M
EPS	-0.49
Shares Out	410.97M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.10 (1.34%)
Ex-Dividend Date	Jul 9, 2026

Volume	2,992,455
Open	7.59
Previous Close	7.60
Day's Range	7.51 - 7.60
52-Week Range	6.83 - 12.42
Beta	0.36
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 31, 2026

About Zhejiang Jianfeng Group

Zhejiang Jianfeng Group Co., Ltd. engages in the building materials and pharmaceuticals business in China. The company offers pharmaceutical products, including antibiotics, cardiovascular drugs, antidepressants, ophthalmic drugs, anti-tumor drugs, and infant medications. It is involved in investment in pharmaceutical and healthcare industries; manufacturing and sales of cement and cement concrete; production and sales of pharmaceutical intermediates; sales of pharmaceutical chemical raw materials; and import and export business; and other indu...

• Industry: Building Materials
• Sector: Materials
• Founded: 1989
• Employees: 1,836
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600668

Financial Performance

In 2025, Zhejiang Jianfeng Group's revenue was 2.57 billion, a decrease of -10.74% compared to the previous year's 2.88 billion. Earnings were 411.90 million, an increase of 281.43%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 9, 2026

Data Sources Report a data error